• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION, INC CHLORAPREP UNKNOWN; 2% W/V CHLORHEXIDINE GLUCONATE/70% V/V ISOPROPYL ALCOHOL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION, INC CHLORAPREP UNKNOWN; 2% W/V CHLORHEXIDINE GLUCONATE/70% V/V ISOPROPYL ALCOHOL Back to Search Results
Catalog Number UNKNOWN
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Skin Irritation (2076)
Event Date 10/29/2020
Event Type  Injury  
Manufacturer Narrative
(b)(4).Initial emdr submission.A follow up emdr will be submitted if additional information becomes available.(b)(4).
 
Event Description
Material no.: unknown batch no.: unknown.It was reported that the patient experienced skin irritation from chloraprep dressing kits.Per medwatch: this [pt info omitted] patient began therapy with remodulin (treprostinil sodium, concentration 2.5 mg/ml) on (b)(6) 2020 for primary pulmonary arterial hypertension.The current dose was reported as 0.046 ug/kg, continuous via intravenous route.On an un reported date in 2020, the patient experienced the event of skin irritation from chloraprep dressing kits (dermatitis contact).Action taken with iv remodulin and chloraprep was not reported for the event of dermatitis contact.At the time of reporting, the outcome of dermatitis contact was unknown.The reporter did not provide causality for the event of dermatitis contact.Diagnosis for use (continued): primary pulmonary arterial hypertension (pulmonary arterial hypertension), drug use for unknown indication (product used for unknown indication).Concomitant medical products (continued): esbriet (pirfenidone).
 
Event Description
It was reported that the patient experienced skin irritation from chloraprep dressing kits.
 
Manufacturer Narrative
No additional information was provided by united therapeutics.Propharma did reach out to obtain with no success.Should additional information be available in the future, the complaint will be re-opened and investigated.All complaints are reviewed during monthly quality/safety meetings.In addition, complaints are trended at monthly quality data analyst meetings and quarterly plant management review meetings.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CHLORAPREP UNKNOWN
Type of Device
2% W/V CHLORHEXIDINE GLUCONATE/70% V/V ISOPROPYL ALCOHOL
Manufacturer (Section D)
CAREFUSION, INC
75 north fairway drive
vernon hills IL 60061
MDR Report Key10817311
MDR Text Key217900811
Report Number3004932373-2020-00124
Device Sequence Number1
Product Code KXF
Combination Product (y/n)N
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other,user facility
Type of Report Initial,Followup
Report Date 11/12/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Device Catalogue NumberUNKNOWN
Device Lot NumberUNKNOWN
Initial Date Manufacturer Received 10/29/2020
Initial Date FDA Received11/10/2020
Supplement Dates Manufacturer Received10/29/2020
Supplement Dates FDA Received11/12/2020
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age74 YR
Patient Weight61
-
-